Geneva, Switzerland, May 8, 2024 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug…
First findings from multi-national patient research underpin the importance of integrating patient needs and preferences into strategies for managing unhealthy…